Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: A phase 2 trial of the eastern cooperative oncology group

Athanassios Argiris, Ashley Buchanan, Bruce Brockstein, Jill Kolesar, Musie Ghebremichael, Michael Pins, Kristine Hahn, Rita Axelrod, Arlene Forastiere

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: A phase 2 trial of the eastern cooperative oncology group'. Together they form a unique fingerprint.

Medicine & Life Sciences